公开(公告)号：US20230257426A1

公开(公告)日：2023-08-17

申请号：US18139003

申请日：2023-04-25

Applicant: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Sangyong JON ,  Sukmo KANG ,  Yujin KIM ,  Ji-Joon SONG

IPC: C07K14/23 ,  C07K14/11 ,  C12N15/63 ,  A61K39/02 ,  A61K39/145 ,  A61P37/04

CPC classification number: C07K14/23 ,  C07K14/11 ,  C12N15/63 ,  A61K39/02 ,  A61K39/145 ,  A61P37/04 ,  A61K2039/10

Abstract: The present disclosure relates to a fusion protein comprising BP26 and an antigenic polypeptide, and to a nanoarchitecture comprising same. A vaccine composition comprising the fusion protein, nanoarchitecture, or combination thereof of the present disclosure can be used to effectively prevent or treat pathogens or cancer, and thus can be used as a multi-purpose vaccine platform.